A possible mechanism of HERV-Ks that counteracts the immune response and drives oncogenesis could include the ovarian cancer susceptibility gene BRCA1 as it carries several HERV-K (HML-2) elements in its sequence [205]. Here, CLEC10A is linked to ovarian carcinoma.